The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2015
Filed:
Sep. 07, 2009
Kyung Sook Chung, Daejeon, KR;
MI Sun Won, Daejeon, KR;
Ji Won Ahn, Nonsan-si, KR;
Jeong Hae Choi, Busan, KR;
Hyang Sook Yoo, Daejeon, KR;
Young IL Yeom, Daejeon, KR;
Eun Young Song, Seoul, KR;
Hee Gu Lee, Daejeon, KR;
Jae Hun Cheong, Busan, KR;
Chang MO Kang, Seoul, KR;
Kyung Sook Chung, Daejeon, KR;
Mi Sun Won, Daejeon, KR;
Ji Won Ahn, Nonsan-si, KR;
Jeong Hae Choi, Busan, KR;
Hyang Sook Yoo, Daejeon, KR;
Young Il Yeom, Daejeon, KR;
Eun Young Song, Seoul, KR;
Hee Gu Lee, Daejeon, KR;
Jae Hun Cheong, Busan, KR;
Chang Mo Kang, Seoul, KR;
Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;
Abstract
Disclosed are novel GPCR (G Protein Coupled Receptor) proteins and genes encoding the same. Also provided is the use of the proteins and the genes. Particularly, contemplated are a novel GPCR (G Protein Coupled Receptor) polypeptide, a polynucleotide coding for the same, a recombinant vector carrying the polynucleotide or a fragment thereof, host cells transformed with the vector, a transgenic animal infected with the vector. Also, a composition for detecting a cancer marker, comprising an agent capable of measuring the expression level of mRNA or protein of the GPCR polynucleotide, a kit for the diagnosis of cancer, comprising the composition, and a method for detecting the GPCR polypeptide and a gene encoding the polypeptide are provided. Further, a composition for the treatment and prevention of cancer, comprising an oligonucleotide inhibiting the expression of a gene encoding the GPCR polypeptide or an antibody against the GPCR protein, and a method for screening a modulator of the GPCR protein or a cancer therapeutic agent are provided.